Abstract
A 21-month-old girl with hemoglobin Bart's hydrops received bone marrow transplantation (BMT) from a matched sibling. No major BMT-related complications developed. Hemoglobin levels remained greater than 10 gm/dl for 20 months without blood transfusion support despite the presence of residual host hemopoietic cells from 2 months after BMT. We suggest consideration of this therapeutic option for surviving patients. © 1998 by Mosby, Inc.
| Original language | English |
|---|---|
| Pages (from-to) | 1039-1042 |
| Journal | Journal of Pediatrics |
| Volume | 132 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 1998 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Treatment of hemoglobin Bart's hydrops with bone marrow transplantation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver